Congo to receive 70,000 doses of Ervebo Ebola vaccine which has been effective in past outbreaks

Congo will receive 70,000 doses of the Ervebo vaccine for use against Ebola, which has been effective in past outbreaks. The allocation includes 20,000 doses for a Phase 3 clinical trial concerning the Bundibugyo virus and 50,000 doses for front-line and health workers. This step aims to boost efforts to contain an Ebola outbreak described as the fastest in history.